tiprankstipranks
Keymed Biosciences, Inc. (HK:2162)
:2162
Hong Kong Market
2162
Keymed Biosciences, Inc.
RESEARCH TOOLSreports
Want to see HK:2162 full AI Analyst Report?

Keymed Biosciences, Inc. (2162) Revenue

1 Followers
StatisticsMarket CapRevenue

Keymed Biosciences, Inc. Revenue

Keymed Biosciences, Inc. had a revenue of 213.93M in the quarter ending Dec 31, 2025, with -57.11%. This bring the company's revenue in the last twelve months to 712.68M, Increased -18.29%. In the fiscal year ending Dec 31, 2025, Keymed Biosciences, Inc. had annual revenue of 697.77M with 62.98% growth.
Revenue (ttm)
712.68M
Revenue Growth
66.66%
P/S Ratio
24.69
Revenue/Employee
HK$554,669
Employees
1,258
Market Cap
HK$17.22B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
697.77M269.65M+62.98%
Dec 31, 2024
428.12M74.03M+20.91%
Dec 31, 2023
354.10M254.03M+253.87%
Dec 31, 2022
100.06M-10.21M-9.26%
Dec 31, 2021
110.27M―+∞%
Dec 31, 2020
―――
Dec 31, 2019
―――